Skip to main content

Table 2 List of MHC class I-restricted peptides used as stimuli

From: Longitudinal changes in HIV-specific IFN-γ secretion in subjects who received Remune™ vaccination prior to treatment interruption

Peptide ID

Sequence Location

Sequence

MHC Restriction (s)

A1-1

p17 (71–79)

GSEELRSLY

A1

A1-2

Nef (121–128)

FPDWQNYT

A1

A1-3

Nef (184–192)

RFDSRLAFH

A1

A2-1

p17 (77–85)

SLYNTVATL

A2

A2-2

RT (309–317)

ILKEPVHGV

A2

A2-3/A3-1

Nef (190–198)

AFHHVAREL

A2, A3

A2-4

p24 (19–27)

TLNAWVKVV

A2

A2-5

RT (179–187)

VIYQYMMDL

A2

A2-6

CMV

NLVPMVATV

A2

A3-2

EBV

IVTDFSVIK

A3, A11, A6801

B7-1

p24 (47–56)

ATPQDLNTML

B7, B58

B7-2

p24 (16–24)

SPRTLNAWV

B7

B7-3/B35-1

Nef (68–77)

FPVTPQVPLR

B7, B35

B7-4

Nef (128–137)

TPGPGVRYPL

B7

B7-5

CMV

TPRVTGGGAM

B7

B7-6

EBV

RPPIFIRRL

B7

B8-1

p24 (127–135)

GEIYKRWII

B8

B8-2

Nef (90–97)

FLKEKGGL

B8

B8-3

p17 (24–31)

GGKKKYKL

B8

B8-4

RT (18–26)

GPKVKQWPL

B8

B8-5

p17 (93–101)

EIKDTKEAL

B8, B60

B8-6

EBV

FLRGRAYGL

B8

B35-2

RT (175–183)

HPDIVIYQY

B35

B35-3

gp160 (41–51)

GVPVWKEATTT

B35

B35-4/B7-7

RT (156–166)

SPAIFQSSMTK

A3, A3.1, A11, A6801, A33, B7, B35

B35-5

Nef (73–82)

QVPLRPMTYK

A3, A11, A31, B27, B35

B44-1

p24 (174–184)

AEQASQDVKNW

B44, B57, Cw4

B44-2

p24 (162–172)

RDYVDRFYKTL

B18, B2601, B44, B70

B44-3

RT (203–212)

EELRQHLLRW

B44

B44-4

RT (397–406)

TWETWWTEYW

B44

Cw7-1

gp160 (37–46)

TVYYGVPVWK

A3, A6801, A11, Cw7